Kevin Kotler discloses 5.9% AngioDynamics (ANGO) stake in 13G filing

Rhea-AI Filing Summary

Kevin Kotler has filed a Schedule 13G reporting beneficial ownership of 2,421,526 shares of AngioDynamics, Inc. common stock, representing 5.9% of the class as of 01/06/2026. He holds sole voting and dispositive power over these shares and reports the stake as passive, not for influencing control.

The filing notes that 313,495 shares are owned in his individual capacity, while the remainder is held in accounts he manages. He also formally disclaims beneficial ownership beyond his pecuniary interest in the reported securities.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

AngioDynamics, Inc.

(Name of Issuer)

Common Stock, par value $.01

(Title of Class of Securities)

03475V101

(CUSIP Number)

01/06/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 03475V101

1

Names of Reporting Persons

KEVIN KOTLER

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,421,526.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,421,526.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,421,526.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.9 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: AngioDynamics, Inc.
(b)	Address of issuer's principal executive offices: 14 Plaza Drive, Latham, New York 12110
Item 2.
(a)	Name of person filing: Kevin Kotler
(b)	Address or principal business office or, if none, residence: Kevin Kotler c/o Broadfin Holdings, LLC 200 Broadhollow Road, Suite 207 Melville, New York 11747
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock, par value $.01
(e)	CUSIP No.: 03475V101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Kevin Kotler - 2,421,526
(b)	Percent of class: Kevin Kotler - 5.9%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Kevin Kotler - 2,421,526
	(ii) Shared power to vote or to direct the vote: Kevin Kotler - 0
	(iii) Sole power to dispose or to direct the disposition of: Kevin Kotler - 2,421,526
	(iv) Shared power to dispose or to direct the disposition of: Kevin Kotler - 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. With the exception of the 313,495 shares of Common Stock, par value $.01, which are owned by Kevin Kotler in his individual capacity, all of the securities reported in this Schedule 13G are directly owned by accounts managed by Kevin Kotler. No such accounts may be deemed to beneficially own more than 5% of the Common Stock, par value $.01.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

KEVIN KOTLER

Signature:	By: /s/ Kevin Kotler
Name/Title:	Kevin Kotler
Date:	02/09/2026

Comments accompanying signature: * The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

FAQ

What stake in AngioDynamics (ANGO) does Kevin Kotler report on this Schedule 13G?

Kevin Kotler reports beneficial ownership of 2,421,526 shares of AngioDynamics common stock, equal to 5.9% of the outstanding class. He has sole voting and dispositive power over these shares, making him a significant but not controlling shareholder based on this disclosure.

Is Kevin Kotler’s AngioDynamics (ANGO) position reported as passive or activist?

The position is reported as passive. Kotler certifies the securities were not acquired and are not held for the purpose of changing or influencing control of AngioDynamics, and are not held in connection with any transaction intended to have that control-related purpose or effect.

How are Kevin Kotler’s AngioDynamics (ANGO) shares held according to the filing?

The filing states 313,495 AngioDynamics shares are owned by Kevin Kotler individually, while the remaining reported securities are directly owned by accounts he manages. No single managed account is deemed to beneficially own more than 5% of the company’s common stock based on this disclosure.

Does Kevin Kotler fully acknowledge beneficial ownership of all reported AngioDynamics (ANGO) shares?

No. Kotler expressly disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in them. The statement clarifies that it should not be considered an admission of beneficial ownership for Section 16 or any other legal purpose.